Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Norethindrone - Generic Drug Details

« Back to Dashboard

What are the generic sources for norethindrone and what is the scope of norethindrone patent protection?

is the generic ingredient in twelve branded drugs marketed by Aurobindo Pharma Ltd, Accord Hlthcare, Glenmark Generics, Novast Labs Ltd, Lupin Ltd, Mayne Pharma, Janssen Pharms, Apil, Amneal Pharms, Novast Labs, Mylan Labs Ltd, Parke Davis, Duramed Res, and Barr, and is included in twenty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for norethindrone. Eighteen suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: norethindrone

Drug Master File Entries: see list26
Suppliers / Packagers: see list18
Bulk Api Vendors: see list40
Clinical Trials: see list18
Patent Applications: see list5,580
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:norethindrone at DailyMed

Pharmacology for Ingredient: norethindrone

Ingredient-typeProgesterone Congeners
Drug ClassProgestin

Tentative approvals for NORETHINDRONE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe1MG;0.01MG;75MGTABLET;ORAL
► Subscribe► Subscribe1MG;0.02MGTABLET;ORAL
► Subscribe► Subscribe75MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma
TABLET;ORAL-28076177-001Oct 21, 2002AB1RXNoNo► Subscribe► Subscribe
Lupin Ltd
TABLET;ORAL-28091323-001Mar 28, 2013AB2RXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
TABLET;ORAL-28201483-001Jun 24, 2013AB1RXNoNo► Subscribe► Subscribe
Glenmark Generics
TABLET;ORAL-28091209-001Jul 22, 2010AB2RXNoNo► Subscribe► Subscribe
Parke Davis
TABLET;ORAL010895-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus